ZA201104032B - 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt - Google Patents
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate saltInfo
- Publication number
- ZA201104032B ZA201104032B ZA2011/04032A ZA201104032A ZA201104032B ZA 201104032 B ZA201104032 B ZA 201104032B ZA 2011/04032 A ZA2011/04032 A ZA 2011/04032A ZA 201104032 A ZA201104032 A ZA 201104032A ZA 201104032 B ZA201104032 B ZA 201104032B
- Authority
- ZA
- South Africa
- Prior art keywords
- heptacosa
- tetracyclo
- triaza
- dioxa
- pyrrolidin
- Prior art date
Links
- 150000001860 citric acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/22—Tricarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D201/00—Preparation, separation, purification or stabilisation of unsubstituted lactams
- C07D201/02—Preparation of lactams
- C07D201/10—Preparation of lactams from cycloaliphatic compounds by simultaneous nitrosylation and rearrangement
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12166808P | 2008-12-11 | 2008-12-11 | |
| PCT/SG2009/000473 WO2010068181A1 (en) | 2008-12-11 | 2009-12-09 | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201104032B true ZA201104032B (en) | 2012-08-29 |
Family
ID=41666397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2011/04032A ZA201104032B (en) | 2008-12-11 | 2011-05-31 | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8980873B2 (enExample) |
| EP (1) | EP2376499B1 (enExample) |
| JP (1) | JP5669748B2 (enExample) |
| KR (1) | KR101729918B1 (enExample) |
| CN (1) | CN102282148B (enExample) |
| AR (2) | AR074724A1 (enExample) |
| AU (1) | AU2009325147B2 (enExample) |
| BR (1) | BRPI0922736B1 (enExample) |
| CA (1) | CA2746058C (enExample) |
| DK (1) | DK2376499T3 (enExample) |
| ES (1) | ES2536558T3 (enExample) |
| HR (1) | HRP20150428T1 (enExample) |
| IL (3) | IL213418A0 (enExample) |
| MX (1) | MX2011006206A (enExample) |
| MY (1) | MY160005A (enExample) |
| NZ (1) | NZ593223A (enExample) |
| PL (1) | PL2376499T3 (enExample) |
| PT (1) | PT2376499E (enExample) |
| RU (1) | RU2527970C2 (enExample) |
| SG (1) | SG171907A1 (enExample) |
| TW (1) | TWI449705B (enExample) |
| WO (1) | WO2010068181A1 (enExample) |
| ZA (1) | ZA201104032B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2376500T3 (pl) * | 2008-12-11 | 2015-07-31 | Cti Biopharma Corp | Sól maleinianowa 11-(2-pirrolidyn-1-yloetoksy)-14,19-dioksa-5,7,26 triazatetracyklo[19.3.1.1(2,6).1(8,12)]heptakosa-1(25),2(26),3,5,8,10,12(27),16,21,23-dekaenu |
| CN102282148B (zh) | 2008-12-11 | 2014-12-24 | Cti生物医药有限公司 | 11-(2-吡咯烷-1-基-乙氧基)-14,19-二氧杂-5,7,26-三氮杂-四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2(26),3,5,8,10,12(27),16,21,23-十烯柠檬酸盐 |
| US9090623B2 (en) | 2012-04-13 | 2015-07-28 | Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. | Compound JK12A and preparation thereof |
| CN105061467B (zh) * | 2015-08-28 | 2017-08-25 | 苏州立新制药有限公司 | 一种帕克替尼的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5728536A (en) | 1993-07-29 | 1998-03-17 | St. Jude Children's Research Hospital | Jak kinases and regulation of Cytokine signal transduction |
| US6136595A (en) | 1993-07-29 | 2000-10-24 | St. Jude Children's Research Hospital | Jak kinases and regulations of cytokine signal transduction |
| CA2446988A1 (en) * | 2001-05-14 | 2002-11-21 | Pfizer Products Inc. | The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| US6433018B1 (en) | 2001-08-31 | 2002-08-13 | The Research Foundation Of State University Of New York | Method for reducing hypertrophy and ischemia |
| IL161326A0 (en) * | 2001-11-29 | 2004-09-27 | Pfizer Prod Inc | Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2 (11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| CN101360751B (zh) | 2005-11-16 | 2011-09-14 | S*Bio私人有限公司 | 氧连接的嘧啶衍生物 |
| CN102282148B (zh) | 2008-12-11 | 2014-12-24 | Cti生物医药有限公司 | 11-(2-吡咯烷-1-基-乙氧基)-14,19-二氧杂-5,7,26-三氮杂-四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2(26),3,5,8,10,12(27),16,21,23-十烯柠檬酸盐 |
-
2009
- 2009-12-09 CN CN200980150325.5A patent/CN102282148B/zh active Active
- 2009-12-09 KR KR1020117015738A patent/KR101729918B1/ko active Active
- 2009-12-09 AU AU2009325147A patent/AU2009325147B2/en active Active
- 2009-12-09 DK DK09788621T patent/DK2376499T3/en active
- 2009-12-09 PT PT97886212T patent/PT2376499E/pt unknown
- 2009-12-09 US US13/133,297 patent/US8980873B2/en active Active
- 2009-12-09 MX MX2011006206A patent/MX2011006206A/es active IP Right Grant
- 2009-12-09 JP JP2011540664A patent/JP5669748B2/ja active Active
- 2009-12-09 ES ES09788621.2T patent/ES2536558T3/es active Active
- 2009-12-09 NZ NZ593223A patent/NZ593223A/xx unknown
- 2009-12-09 BR BRPI0922736-9A patent/BRPI0922736B1/pt active IP Right Grant
- 2009-12-09 PL PL09788621T patent/PL2376499T3/pl unknown
- 2009-12-09 MY MYPI2011002647A patent/MY160005A/en unknown
- 2009-12-09 CA CA2746058A patent/CA2746058C/en active Active
- 2009-12-09 EP EP09788621.2A patent/EP2376499B1/en active Active
- 2009-12-09 SG SG2011040060A patent/SG171907A1/en unknown
- 2009-12-09 RU RU2011126173/04A patent/RU2527970C2/ru active
- 2009-12-09 WO PCT/SG2009/000473 patent/WO2010068181A1/en not_active Ceased
- 2009-12-09 HR HRP20150428TT patent/HRP20150428T1/hr unknown
- 2009-12-11 AR ARP090104834A patent/AR074724A1/es not_active Application Discontinuation
- 2009-12-11 TW TW098142605A patent/TWI449705B/zh active
-
2011
- 2011-05-31 ZA ZA2011/04032A patent/ZA201104032B/en unknown
- 2011-06-06 IL IL213418A patent/IL213418A0/en unknown
-
2015
- 2015-02-13 US US14/621,726 patent/US9624242B2/en active Active
-
2017
- 2017-01-26 IL IL250310A patent/IL250310A0/en unknown
-
2019
- 2019-03-20 AR ARP190100701A patent/AR114133A2/es unknown
-
2021
- 2021-12-26 IL IL289379A patent/IL289379A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289379A (en) | Citrate salt of 11-(2-pyrrolidin-1-yl-ethoxy)-19,14-dioxa-26,7,5-triaza-tetracyclo[1.1.3.19(6,2)1(12,8)]hepatacosa- 1(25),2(26),12,10,8,5,3(27)j23,21,16–Decan | |
| HUS1800031I1 (hu) | Dioxa-biciklo[3.2.1.]oktán-2,3,4-triol származékok | |
| IL242665B (en) | Processes for preparing anti-tricyclo[3.2.2.0]non-6-ene-endo-8,endo-9-dicarboxylic acid anhydride | |
| AP3099A (en) | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol de derivatives | |
| IL206765A0 (en) | 4,5-dihydro-oxazol-2-yl-amine derivatives | |
| PL2013208T3 (pl) | Pirydyno[3,4-B]pirazynowy | |
| ZA201006732B (en) | 2-aza-bicyclo[2.2.1]heptane derivatives | |
| ZA200805354B (en) | Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives | |
| IL190997A0 (en) | New highly stable aqueous solution, electrode with nanocoating for preparing the solution and method for making this electrode | |
| IL188431A0 (en) | Process for preparing 3-arylmethylthio-and 3-heteroarylmethylthio-4,5-dihydro- | |
| AP2283A (en) | Stable aqueous suspension. | |
| IL210074A (en) | Process for the preparation of pyrido derivatives [2, 3 – d] pyrimidine-7-il-phenyl | |
| PL2376500T3 (pl) | Sól maleinianowa 11-(2-pirrolidyn-1-yloetoksy)-14,19-dioksa-5,7,26 triazatetracyklo[19.3.1.1(2,6).1(8,12)]heptakosa-1(25),2(26),3,5,8,10,12(27),16,21,23-dekaenu | |
| PL2454266T3 (pl) | Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu | |
| IL206666A0 (en) | N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2- | |
| ZA200803501B (en) | New highly stable aqueous solution, electrode with nanocoating for preparing the solution and method for making this electrode | |
| IL206668A0 (en) | N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2- | |
| IL200166A0 (en) | New process for preparing 3-methyl-4-phenylisoxazolo[3,4-d]pyridazin-7(6h)-one | |
| IL187673A0 (en) | Process for preparing 3,3-diarylpropylamines | |
| PL1801429T3 (pl) | Złącze narożne, zwłaszcza dla wózka do serwowania | |
| TH0901005537B (th) | 11-(2-ไพร์โรลิดิน-1-อิล-เอทอกซี)-14,19-ไดออกซา-5,7,26-ไตรอะซา-เตตราไซโคล[19.3.1.1(2,6).1(8,12)]เฮปทาโคซา-1(25),2(26),3,5,8,10,12(27),16,21,23-เดคาอีน มาลีเอท ซอลท์ | |
| IL198203A0 (en) | Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols | |
| IL180493A (en) | Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |